These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38329920)

  • 1. Intraperitoneal vancomycin plus levofloxacin for the treatment of peritoneal dialysis-related peritonitis in patients with no response to cefazolin plus ceftazidime.
    Zhou J; Huang Y; Zhang X; Xiong L; Zhang R; Shi H
    Clin Nephrol; 2024 Apr; 101(4):164-170. PubMed ID: 38329920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic analysis of ceftazidime and cefazolin in the treatment of continuous ambulatory peritoneal dialysis-related peritonitis.
    Zhu W; Fang X; Zheng J; Ke Y; He Q; Cui T; Chen B; Tian L
    Ren Fail; 2023; 45(2):2285873. PubMed ID: 38044852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen.
    Goldberg L; Clemenger M; Azadian B; Brown EA
    Am J Kidney Dis; 2001 Jan; 37(1):49-55. PubMed ID: 11136167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefazolin and netilmycin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis.
    Gucek A; Bren AF; Hergouth V; Lindic J
    Adv Perit Dial; 1997; 13():218-20. PubMed ID: 9360685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis-Related Peritonitis: A Randomized Controlled Pilot Study.
    Xu R; Yang Z; Qu Z; Wang H; Tian X; Johnson DW; Dong J
    Am J Kidney Dis; 2017 Jul; 70(1):30-37. PubMed ID: 28027794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function.
    Lui SL; Cheng SW; Ng F; Ng SY; Wan KM; Yip T; Tse KC; Lam MF; Lai KN; Lo WK
    Kidney Int; 2005 Nov; 68(5):2375-80. PubMed ID: 16221243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal Cefepime Monotherapy Versus Combination Therapy of Cefazolin Plus Ceftazidime for Empirical Treatment of CAPD-Associated Peritonitis: A Multicenter, Open-Label, Noninferiority, Randomized, Controlled Trial.
    Kitrungphaiboon T; Puapatanakul P; Chuengsaman P; Tiskajornsiri K; Halue G; Siribamrungwong M; Matayart S; Chongthanakorn K; Poonvivatchaikarn U; Boonyakrai C; Somboonsilp W; Katavetin P; Praditpornsilpa K; Eiam-Ong S; Johnson DW; Kanjanabuch T
    Am J Kidney Dis; 2019 Nov; 74(5):601-609. PubMed ID: 31331757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment of peritoneal dialysis-associated peritonitis with cefazolin and ceftazidime in children.
    Rusthoven E; Monnens LA; Schröder CH
    Perit Dial Int; 2001; 21(4):386-9. PubMed ID: 11587402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS).
    Schaefer F; Klaus G; Müller-Wiefel DE; Mehls O
    J Am Soc Nephrol; 1999 Jan; 10(1):136-45. PubMed ID: 9890319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized prospective comparison of oral levofloxacin plus intraperitoneal (IP) vancomycin and IP netromycin plus IP vancomycin as primary treatment of peritonitis complicating CAPD.
    Cheng IK; Fang GX; Chau PY; Chan TM; Tong KL; Wong AK; Li CS; Lo WK; Cheung KO; Kumana CR
    Perit Dial Int; 1998; 18(4):371-5. PubMed ID: 10505557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenging the current treatment paradigm for methicillin-resistant Staphylococcus epidermidis peritonitis in peritoneal dialysis patients.
    Ariano RE; Franczuk C; Fine A; Harding GK; Zelenitsky SA
    Perit Dial Int; 2002; 22(3):335-8. PubMed ID: 12227390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients.
    Khairullah Q; Provenzano R; Tayeb J; Ahmad A; Balakrishnan R; Morrison L
    Perit Dial Int; 2002; 22(3):339-44. PubMed ID: 12227391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rare case of successful treatment of peritoneal dialysis patient with
    Xie R; Ling Y; Huang Y; Qin L; Bao K; Qin X
    Front Cell Infect Microbiol; 2024; 14():1373036. PubMed ID: 38873095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of peritonitis in children on peritoneal dialysis: a 25-year experience at Severance Hospital.
    Lee KO; Park SJ; Kim JH; Lee JS; Kim PK; Shin JI
    Yonsei Med J; 2013 Jul; 54(4):983-9. PubMed ID: 23709435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and outcome of peritonitis in automated peritoneal dialysis, using a once-daily cefazolin-based regimen.
    Fielding RE; Clemenger M; Goldberg L; Brown EA
    Perit Dial Int; 2002; 22(3):345-9. PubMed ID: 12227392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus on peritonitis treatment in pediatric patients?
    Schröder CH; Rusthoven E; Monnens LA
    Perit Dial Int; 2002; 22(1):87-9. PubMed ID: 11930942
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraperitoneal cefazolin and ceftazidime during short-dwell exchange in peritoneal dialysis patients with peritonitis.
    Triyawatanyu P; Chariyavilaskul P; Phaisal W; Peerapornratana S; Kanjanabuch T; Praditpornsilpa K; Katavetin P
    Perit Dial Int; 2020 Mar; 40(2):179-184. PubMed ID: 32063189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 12-month review of peritoneal dialysis-related peritonitis in Western Australia: is empiric vancomycin still indicated for some patients?
    Kan GW; Thomas MA; Heath CH
    Perit Dial Int; 2003; 23(5):465-8. PubMed ID: 14604199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) with co-trimoxazole, cefazolin or vancomycin].
    König U; Müller U; Binswanger U
    Klin Wochenschr; 1987 Jul; 65(12):562-70. PubMed ID: 3498086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent and relapsing peritonitis: causative organisms and response to treatment.
    Szeto CC; Kwan BC; Chow KM; Law MC; Pang WF; Chung KY; Leung CB; Li PK
    Am J Kidney Dis; 2009 Oct; 54(4):702-10. PubMed ID: 19577352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.